Lista de obras -

A Report of the 24th Annual Congress on Women's Health-Workshop on Transforming Women's Health: From Research to Practice

artículo científico publicado en 2018

A Report of the Women's Health Congress Workshop on The Health of Women of Color: A Critical Intersection at the Corner of Sex/Gender and Race/Ethnicity

artículo científico publicado en 2016

A comparison of initial duloxetine dosing strategies in patients with major depressive disorder

artículo científico

A genomewide association study of citalopram response in major depressive disorder-a psychometric approach

artículo científico publicado en 2010

A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction

artículo científico publicado en 2004

A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women

artículo científico publicado en 2015

A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy.

artículo científico publicado en 2008

Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status

artículo científico publicado en 2007

An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder

artículo científico publicado en 2016

An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder

artículo científico publicado en 2009

An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.

artículo científico publicado en 2009

Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder

artículo científico publicado en 2010

Analysis of depressive symptoms in patients with major depressive disorder treated with desvenlafaxine or placebo

artículo científico publicado en 2009

Assessing anxious features in depressed outpatients.

artículo científico publicado en 2011

Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study

artículo científico publicado en 2009

Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study

artículo científico publicado en 2008

Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials

artículo científico publicado en 2009

Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol

artículo científico publicado en 2012

Beyond remission: rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study.

artículo científico publicado en 2006

Blue Again: Perturbational Effects of Antidepressants Suggest Monoaminergic Homeostasis in Major Depression ⬇️

artículo científico publicado el 7 de julio de 2011

Burden of premenstrual dysphoric disorder on health-related quality of life

artículo científico publicado en 2008

Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder

artículo científico publicado en 2007

Chronic depression and comorbid personality disorders: response to sertraline versus imipramine

artículo científico publicado en 2003

Chronic depression in women

artículo científico publicado en 2002

Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.

artículo científico publicado en 2005

Clinical Characteristics and Treatment Response to Lisdexamfetamine Dimesylate Versus Placebo in Adults With Binge Eating Disorder: Analysis by Gender and Age

scientific article published on 26 February 2019

Clinical features of treatment-resistant depression.

artículo científico publicado en 2001

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

artículo científico publicado en 2011

Communication between physicians and patients with suspected or diagnosed binge eating disorder

artículo científico publicado en 2014

Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study

artículo científico publicado en 2011

Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction

artículo científico publicado en 2000

Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

artículo científico publicado en 2010

Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.

artículo científico publicado en 2003

Correlates of Postpartum Visits Among Medicaid Recipients: An Analysis Using Claims Data from a Managed Care Organization

artículo científico publicado en 2018

Correlation between patient and clinician assessments of depression severity in the PREVENT study

artículo científico publicado en 2010

Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment

artículo científico publicado en 2008

Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder

artículo científico publicado en 2010

Desvenlafaxine for the treatment of major depressive disorder

artículo científico publicado en 2014

Determination of Premenstrual Symptom Exacerbations ⬇️

artículo científico publicado el 1 de septiembre de 2011

Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool

artículo científico publicado en 2008

Differential diagnosis of chronic depressive disorders

artículo científico publicado en 1996

Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression

artículo científico publicado en 2002

Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.

artículo científico publicado en 2003

Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study

artículo científico publicado en 2013

Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination

artículo científico publicado en 2002

Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression

artículo científico publicado en 2002

Duloxetine Efficacy for Major Depressive Disorder in Male vs. Female Patients

scholarly article by Susan G. Kornstein et al published 15 May 2006 in The Journal of Clinical Psychiatry

Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial

artículo científico publicado en 2007

Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials

artículo científico publicado en 2006

Duloxetine in practice-based clinical settings: assessing effects on the emotional and physical symptoms of depression in an open-label, multicenter study

artículo científico publicado en 2007

Duloxetine in the treatment of generalized anxiety disorder

artículo científico publicado en 2009

Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients

artículo científico publicado en 2006

Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.

artículo científico publicado en 2010

Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint

artículo científico publicado en 2008

Editor's Note

Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis

artículo científico publicado en 2017

Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis

artículo científico publicado en 2015

Effects of sex and gender on adaptation to space: behavioral health

artículo científico publicado en 2014

Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder

artículo científico publicado en 2013

Enhancing pharmacologic effects in the treatment of depression in women

artículo científico publicado en 2000

Epidemiology and Recognition of Binge-Eating Disorder in Psychiatry and Primary Care

artículo científico publicado en 2017

Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.

artículo científico publicado en 2006

Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.

artículo científico publicado en 2009

Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs

artículo científico publicado en 2006

Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression

artículo científico publicado en 2008

Focus on Women's Mental Health

artículo científico publicado en 2011

Gender differences in chronic major and double depression

artículo científico publicado en 2000

Gender differences in depression and response to antidepressant treatment ⬇️

artículo científico publicado el 1 de septiembre de 2003

Gender differences in depression: findings from the STAR*D study.

artículo científico publicado en 2005

Gender differences in depression: implications for treatment

artículo científico publicado el 1 de enero de 1997

Gender differences in presentation of chronic major depression.

artículo científico publicado en 1995

Gender differences in treatment response to sertraline versus imipramine in chronic depression

artículo científico publicado en 2000

Gender issues and DSM-V.

artículo científico publicado en 2010

Gender-specific differences in depression and treatment response.

artículo científico publicado en 2002

Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations

artículo científico publicado en 2018

Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations

artículo científico publicado en 2018

Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

artículo científico publicado en 2018

Implications of pain in generalized anxiety disorder: efficacy of duloxetine

artículo científico publicado en 2008

Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study

artículo científico publicado en 2014

Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression

artículo científico publicado en 2007

Interpreting Premenstrual Symptoms Impact Survey scores using outcomes in health-related quality of life and sexual drive impact.

artículo científico publicado en 2010

Journal of Women’s Health. Message from the editor

artículo científico publicado en 2012

Long-term function and psychosocial outcomes with venlafaxine extended release 75-225 mg/day versus placebo in the PREVENT study

artículo científico publicado en 2017

Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder

artículo científico publicado en 2008

Lost human capital from early-onset chronic depression

artículo científico publicado en 2000

Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies

artículo científico publicado en 2006

Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study

artículo científico publicado en 2008

Menstrual migraines: etiology, treatment, and relationship to premenstrual syndrome

artículo científico publicado el 1 de junio de 1997

Mental symptoms and disorders during pregnancy

artículo científico publicado en 2004

Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram

artículo científico

Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder

artículo científico publicado en 2014

Postpartum Visit Attendance Increases the Use of Modern Contraceptives

artículo científico publicado en 2016

Potential long-term effects of a mind-body intervention for women with major depressive disorder: sustained mental health improvements with a pilot yoga intervention.

artículo científico publicado en 2014

Preface: Advances in women's mental health

artículo científico publicado en 2010

Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study

artículo científico

Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release

artículo científico publicado en 2010

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.

artículo científico publicado en 2011

Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.

artículo científico publicado en 2003

Recognizing Binge-Eating Disorder in the Clinical Setting: A Review of the Literature

artículo científico publicado en 2016

Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions

artículo científico publicado en 2007

Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions

artículo científico publicado en 2005

Remission as the critical outcome of depression treatment

artículo científico publicado en 2002

Remission of maternal depression: relations to family functioning and youth internalizing and externalizing symptoms.

artículo científico publicado en 2008

Residual Symptoms in Major Depressive Disorder: Prevalence, Effects, and Management

artículo científico publicado el 1 de abril de 2013

Response to Weissman and Markowitz re: "Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations"

scientific article published on 13 February 2019

Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients

artículo científico publicado en 2005

Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression

artículo científico publicado en 2005

Sertraline versus imipramine to prevent relapse in chronic depression.

artículo científico publicado en 2001

Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study

scientific article published on 04 March 2008

Sex differences in response to citalopram: a STAR*D report

artículo científico publicado en 2008

Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination

artículo científico publicado en 2002

Short-Term Efficacy and Safety of Desvenlafaxine in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder

artículo científico publicado el 1 de agosto de 2010

Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines

artículo científico publicado en 2004

Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial

artículo científico publicado en 2015

Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination

artículo científico publicado en 2002

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

article

The Influence of Cyclic Hormonal Contraception on Expression of Premenstrual Syndrome.

artículo científico publicado en 2016

The P revention of R ecurrent E pisodes of Depression with Ven lafaxine for T wo Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases

article

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

artículo científico

The clinical relevance of self-reported premenstrual worsening of depressive symptoms in the management of depressed outpatients: a STAR*D report

artículo científico publicado en 2013

The effect of desvenlafaxine 50 mg/day on a subpopulation of anxious/depressed patients: a pooled analysis of seven randomized, placebo-controlled studies

artículo científico publicado en 2014

The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD.

artículo científico publicado en 2015

The evaluation and management of depression in women across the life span

artículo científico publicado el 1 de enero de 2001

The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women.

artículo científico publicado en 2010

The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.

artículo científico publicado en 1998

The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.

artículo científico publicado en 1998

Therapist Variables That Predict Symptom Change in Psychotherapy With Chronically Depressed Outpatients

Tight binding inhibitors—IX

artículo científico publicado en 1981

Toward more individualized medicine: introducing the Women of Color Health Data Book, Fourth Edition

artículo científico publicado en 2014

Two years of maintenance treatment with venlafaxine xr 75-225 mg/d: Efficacy in patients with recurrent unipolar major depression

Vilazodone efficacy in subgroups of patients with major depressive disorder: a post-hoc analysis of four randomized, double-blind, placebo-controlled trials

artículo científico publicado en 2018

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

artículo científico publicado en 2008

Why do faculty leave? Reasons for attrition of women and minority faculty from a medical school: four-year results

artículo científico publicado en 2008

Women in medicine: shaping the future

artículo científico publicado el 1 de enero de 1998

Women's Mental Health: Progress and Realities

artículo científico publicado en 2017

Working Together to Address Women's Health in Research and Drug Development: Summary of the 2017 Women's Health Congress Preconference Symposium

artículo científico publicado en 2018

Lista de obras de

A Report of the 24th Annual Congress on Women's Health-Workshop on Transforming Women's Health: From Research to Practice

A Report of the Women's Health Congress Workshop on The Health of Women of Color: A Critical Intersection at the Corner of Sex/Gender and Race/Ethnicity

A comparison of initial duloxetine dosing strategies in patients with major depressive disorder

A genomewide association study of citalopram response in major depressive disorder-a psychometric approach

A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction

A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women

A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy.

Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status

An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder

An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder

An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.

Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder

Analysis of depressive symptoms in patients with major depressive disorder treated with desvenlafaxine or placebo

Assessing anxious features in depressed outpatients.

Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study

Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study

Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials

Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol

Beyond remission: rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study.

Blue Again: Perturbational Effects of Antidepressants Suggest Monoaminergic Homeostasis in Major Depression ⬇️

Burden of premenstrual dysphoric disorder on health-related quality of life

Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder

Chronic depression and comorbid personality disorders: response to sertraline versus imipramine

Chronic depression in women

Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.

Clinical Characteristics and Treatment Response to Lisdexamfetamine Dimesylate Versus Placebo in Adults With Binge Eating Disorder: Analysis by Gender and Age

Clinical features of treatment-resistant depression.

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

Communication between physicians and patients with suspected or diagnosed binge eating disorder

Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study

Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction

Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.

Correlates of Postpartum Visits Among Medicaid Recipients: An Analysis Using Claims Data from a Managed Care Organization

Correlation between patient and clinician assessments of depression severity in the PREVENT study

Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment

Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder

Desvenlafaxine for the treatment of major depressive disorder

Determination of Premenstrual Symptom Exacerbations ⬇️

Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool

Differential diagnosis of chronic depressive disorders

Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression

Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.

Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study

Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination

Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression

Duloxetine Efficacy for Major Depressive Disorder in Male vs. Female Patients

Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial

Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials

Duloxetine in practice-based clinical settings: assessing effects on the emotional and physical symptoms of depression in an open-label, multicenter study

Duloxetine in the treatment of generalized anxiety disorder

Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients

Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.

Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint

Editor's Note

Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis

Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis

Effects of sex and gender on adaptation to space: behavioral health

Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder

Enhancing pharmacologic effects in the treatment of depression in women

Epidemiology and Recognition of Binge-Eating Disorder in Psychiatry and Primary Care

Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.

Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.

Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs

Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression

Focus on Women's Mental Health

Gender differences in chronic major and double depression

Gender differences in depression and response to antidepressant treatment ⬇️

Gender differences in depression: findings from the STAR*D study.

Gender differences in depression: implications for treatment

Gender differences in presentation of chronic major depression.

Gender differences in treatment response to sertraline versus imipramine in chronic depression

Gender issues and DSM-V.

Gender-specific differences in depression and treatment response.

Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations

Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations

Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Implications of pain in generalized anxiety disorder: efficacy of duloxetine

Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study